BriaCell Therapeutics Corp. Warrant (BCTXZ) Total Return Calculator with Dividends Reinvested

BriaCell Therapeutics Corp. Warrant

Popular:

The total return for BriaCell Therapeutics Corp. Warrant (BCTXZ) stock is -92.17% over the past 12 months. So far it's down 72.74% this year. The 5-year total return is -93.96%, meaning $10,000 invested in BCTXZ stock 5 years ago would be worth $604 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in BCTXZ 1 year ago, it would be worth $754 today — you'd have lost $9,246.

With Dividends Reinvested$754-92.46%

Price Only (No DRIP)$754-92.46%

Period2025-06-30 → 2026-06-26

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in BCTXZ

1Y$783-$9,217 (-92.2%)-92.2% CAGR

3Y$604-$9,396 (-94.0%)-60.8% CAGR

5Y$604-$9,396 (-94.0%)-43.0% CAGR

10Y$604-$9,396 (-94.0%)-24.5% CAGR

15Y$604-$9,396 (-94.0%)-17.1% CAGR

20Y$604-$9,396 (-94.0%)-13.1% CAGR

30Y$604-$9,396 (-94.0%)-8.9% CAGR

BriaCell Therapeutics Corp. Warrant did not pay dividends during this period. Total return = price return.

Loading BCTXZ total return...

As of 2026-06-28

Performance Summary

Best Year-77.85%2025

Max Drawdown-94.37%2025-06-26 → 2026-06-05

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-72.74%	—	-72.47%	—	$2,726
1Y	-92.17%	-92.17%	-92.53%	+0.36 pp	$783
3Y	-93.96%	-60.77%	-93.90%	—	$604
5Y	-93.96%	-42.96%	-93.90%	—	$604
10Y	-93.96%	-24.47%	-93.90%	—	$604
15Y	-93.96%	-17.07%	-93.90%	—	$604
20Y	-93.96%	-13.09%	-93.90%	—	$604
30Y	-93.96%	-8.93%	-93.90%	—	$604

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-42.25%	-42.25%	—	+0.41%	-42.7pp
2025	-77.85%	-77.85%	—	+16.64%	-94.5pp

BCTXZ underperformed the S&P 500 by 113.01pp over the past year (-92.17% vs +20.84%).

Loading summary...

BCTXZ Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
BCTXZBriaCell Therapeutics Corp. Warrant	$579,314	+0.4%	-72.7%	-92.2%	—	-94.0%	-94.0%	-94.0%
NKTRNektar Therapeutics	$1.2B	-2.9%	+49.5%	+165.4%	—	+621.1%	-74.6%	-69.9%
ADCTADC Therapeutics S.A.	$130M	-70.9%	-69.5%	-62.3%	—	-46.2%	-95.7%	-96.4%
SNDXSyndax Pharmaceuticals, Inc.	$1.9B	+7.1%	-6.2%	+116.7%	—	-4.9%	+10.1%	+87.4%
AGENAgenus Inc.	$126M	-8.7%	-9.6%	-41.6%	—	-91.1%	-97.3%	-96.3%
HALOHalozyme Therapeutics, Inc.	$8.9B	+9.1%	+1.2%	+32.0%	—	+104.2%	+56.2%	+743.0%
IOVAIovance Biotherapeutics, Inc.	$1.5B	+3.7%	+68.5%	+125.8%	—	-43.6%	-83.7%	-46.0%
FATEFate Therapeutics, Inc.	$245M	-2.3%	+108.1%	+76.1%	—	-58.6%	-97.6%	+9.0%
NKGNNKGen Biotech, Inc. Common Stock	$3M	+0.0%	+20.0%	-75.0%	—	-98.9%	-98.9%	-98.9%
CRISCuris, Inc.	$61M	-36.8%	-65.3%	-84.5%	—	-97.7%	-99.8%	-99.8%
IMVTImmunovant, Inc.	$8.0B	+14.8%	+47.5%	+138.9%	—	+98.5%	+247.5%	+284.1%

Compare:BCTXZ vs NKTR BCTXZ vs ADCT BCTXZ vs SNDX BCTXZ vs NKTR vs ADCT

About BCTXZ Dividend Returns

BriaCell Therapeutics Corp. Warrant (BCTXZ) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of BCTXZ over the past year?

BriaCell Therapeutics Corp. Warrant (BCTXZ) delivered a return of -92.17% over the past year. Since BCTXZ does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in BCTXZ be worth today?

A $10,000 investment in BriaCell Therapeutics Corp. Warrant one year ago would be worth $783 today, representing a loss of $9,217.

Q3Does BCTXZ pay dividends?

BriaCell Therapeutics Corp. Warrant (BCTXZ) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BCTXZ, the total return equals the price-only return.

Q4Did BCTXZ beat the S&P 500?

No, BriaCell Therapeutics Corp. Warrant (BCTXZ) underperformed the S&P 500 by 113.01 percentage points over the past year. BCTXZ delivered a total return of -92.17%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed BCTXZ by 113.01pp during this period.

Q5What is BCTXZ's worst drawdown?

BriaCell Therapeutics Corp. Warrant (BCTXZ) experienced a maximum drawdown of -94.37% over the past year, declining from its peak on 2025-06-26 to its trough on 2026-06-05. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is BCTXZ's long-term total return over 10, 20, or 30 years?

Here are BriaCell Therapeutics Corp. Warrant (BCTXZ)'s long-term returns with dividends reinvested. Over 10 years, the total return is -94.0% (-24.5% CAGR) — $10,000 would have grown to $604. Over 20 years: -94.0% total return (-13.1% CAGR) — $10,000 → $604. Over 30 years: -94.0% total return (-8.9% CAGR) — $10,000 → $604. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

How much would $100/month in BCTXZ be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →